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KEYWORDS	
	 The	 reaction	 between	 2‐mercapto‐3H‐chromeno[4,3‐d]pyrimidine‐4,5‐dione	 (1)	 or	 its	 2‐methylthio	 derivative	 (7)	 with	 hydrazonoyl	 halides	 (2)	 in	 dioxane	 under	 ultrasound
irradiation	 in	 the	 presence	 of	 chitosan	 yielded	 chromeno[4,3‐d][1,2,4]triazolo[4,3‐
a]pyrimidine	 derivatives	 (5a‐r).	 On	 the	 other	 hand,	 the	 reaction	 of	 compound	 1	 with	 the
appropriate	 active	 chloromethylene	 compounds	 (9b,	 h	 and	 m)	 followed	 by	 coupling	 the
products	 with	 benzenediazonium	 chloride	 afforded	 the	 azo	 coupling	 products	 which
converted	in	situ	to	compound	5.	The	reaction	mechanism	was	proposed	and	the	structure	of
the	newly	synthesized	compounds	were	established	on	the	basis	of	spectral	data	(Mass,	IR,	1H
and	13C	NMR)	and	elemental	analyses.	
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1.	Introduction	
	
Benzopyranopyrimidine	 derivatives	 are	 reported	 to	
possess	 significant	 applications,	 as	 anticoagulant	 [1],	
antihrombotics	 [2],	 estrogenic	 activity	 on	 MCF‐7	 breast	
carcinoma	 cells	 [3]	 and	 antagonists	 as	 potential	 antipsychotic	
agents	[4].	In	view	of	these	useful	properties,	it	is	not	surprising	
that	 the	 development	 of	 synthetic	 approaches	 to	 these	 ring	
systems	 has	 attracted	 considerable	 interest	 over	 the	 years.	
Moreover,	 nitrogen‐containing	 heterocycles	 are	 also	 of	 broad	
pharmaceutical	 interest	 and	 significance,	 which	 justifies	 our	
continuing	efforts	 in	 exploring	synthetic	strategies	which	 lead	
to	 structures	 formed	 from	 a	 combination	 of	 both	 types	 of	
heterocycles.	 This	 can	 also	 provide	 useful	 information	
regarding	 structural‐activity	 relationship	 in	 this	 area.	
Furthermore,	ultrasound	irradiation	has	been	established	as	an	
important	technique	in	synthetic	organic	chemistry.	It	has	been	
used	 as	 an	 efficient	 heating	 source	 for	 organic	 reactions.	
Shorter	 reaction	 time	 is	 the	 main	 advantage	 of	 ultrasound‐
assisted	 reactions;	 simple	 experimental	 procedure,	 very	 high	
yields,	 increased	 selectivity	 and	 clean	 reactions	 of	 many	
ultrasound‐induced	 organic	 transformations	 offers	 additional	
conveniences	 in	 the	 field	of	 synthetic	organic	 chemistry	 [5‐8].	
The	 beneficial	 effects	 of	 ultrasound	 irradiation	 are	 playing	 an	
increasing	role	in	process	chemistry,	especially	in	cases	where	
classical	 methods	 require	 drastic	 conditions	 or	 prolonged	
reactions	times.	
The	results	 found	by	Thoraya	et	al.	 [9]	on	their	work	on	a	
starting	material	with	somewhat	related	structure	to	ours	were	
very	 promising	 to	 us	 although	 using	 normal	 heating	
procedures;	 this	 is	 because	 the	 prepared	 compounds	 showed	
promising	activities	against	HCV,	H1N1,	and	could	also	be	used	
as	 antiandrogenic	 agents.	 Thus,	 in	 this	 paper,	 we	 aimed	 to	
improve	 the	synthetic	procedure	 for	such	 type	of	compounds.	
This	 could	 be	 accomplished	 through	 the	 interaction	 of	
hydrazonyl	halides	with	the	title	compound	1	under	ultrasound	
irradiation	 as	 ecofriendly	 energy	 source	 and	 using	 the	 eco‐
friendly	 naturally	 occurring	 chitosan	 catalyst	 which	 has	 been	
previously	used	for	similar	synthesis	[9‐11].		
	
2.	Experimental	
	
2.1.	Instrumentation	
	
Melting	 points	 were	 determined	 on	 a	 Gallenkamp	
apparatus	 and	 are	 uncorrected.	 IR	 spectra	 were	 recorded	 in	
potassium	 bromide	 using	 Pye‐Unicam	 SP300	 spectro‐
photometer.	 1H	 and	 13C	 NMR	 spectra	 were	 recorded	 in	
deuterated	 DMSO‐d6	 using	 a	 Varian	 Gemini	 300	 NMR	
spectrometer	(300	MHz	for	1H	NMR	and	75	MHz	for	13C	NMR)	
and	 the	 chemical	 shifts	 were	 related	 to	 that	 of	 the	 solvent	
DMSO‐d6.	 Mass	 spectra	 were	 recorded	 on	 a	 GCMS‐Q1000‐EX	
Shimadzu	 and	 GCMS	 5988‐A	 HP	 spectrometers,	 the	 ionizing	
voltage	was	 70	 eV.	 Irradiation	was	 done	 in	 an	 ultrasonicator,	
(Electric	 supply:	 230	 V,	 A.C.	 50	 Hz,	 1phase;	 Ultrasonic	
frequency:	 36	 KHz;	 Ultrasonic	 power:	 100W).	 Elemental	
analyses	of	the	products	were	carried	out	at	the	Microanalytical	
Centre	of	Cairo	University,	Giza,	Egypt.		
	
2.2.	Synthesis	
	
2‐Mercapto‐3H‐chromeno[4,3‐d]pyrimidine‐4,5‐dione	 (2)	
[12]	 and	 its	 3‐methylthio	 derivative	 (7)	 [13]	 and	 the	
hydrazonoyl	 halides	2	 [14‐17]	were	prepared	 as	described	 in	
the	literature.	
	
2.2.1.	Synthesis	of	9,11‐disubstituted	6H‐chromeno[4,3‐d]	
[1,2,4]triazolo[4,3‐a]pyrimidine‐6,7(11H)‐dione	(5a‐r)	
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Method	A:	To	a	mixture	of	equimolar	amounts	of	compound	
1	and	the	appropriate	hydrazonoyl	halides	2	(10	mmol	each)	in	
dioxane	 (50	 mL)	 was	 added	 chitosan	 (0.1	 g).	 The	 reaction	
mixture	was	 irradiated	by	an	ultrasonic	generator	 in	a	water‐
bath	at	40‐50	°C	for	40	min.	(irradiation	was	continued	till	all	of	
the	 starting	 materials	 have	 been	 disappeared	 and	 hydrogen	
sulfide	 gas	 ceased	 to	 evolve,	 monitored	 by	 TLC).	 The	 hot	
solution	was	 filtered	 to	remove	chitosan	 then	 the	solvent	was	
evaporated	and	the	residue	was	triturated	with	methanol.	The	
solid	 that	 formed	 was	 filtered	 and	 recrystallized	 from	
appropriate	solvent	to	give	compounds	5	(Scheme	1).	
Method	B:	 Treatment	 of	 the	 methylthio	 derivative	7	 with	
hydrazonoyl	halides	2	following	the	same	procedure	in	method	
A	led	to	formation	of	products	which	were	found	to	be	identical	
in	 all	 respects	 (M.p.,	 mixed	 m.p.	 and	 IR)	 with	 products	 5	
(Scheme	2).		
9,11‐Diphenyl‐6H‐chromeno[4,3‐d][1,2,4]triazolo[4,3‐a]	
pyrimidine‐6,7(11H)‐dione	 (5a):	 Yield:	 75%,	 crystallized	 from	
dioxane	 as	white	microcystals.	M.p.:	 324	 oC.	 IR	 (KBr,	 ν,	 cm‐1):	
1735	(δ‐lactone),	1658	(CO	amide).	1H	NMR	(300	MHz,	DMSO‐
d6,	δ,	ppm):	6.79‐8.30	(m,	14H,	Ar‐H).	13C	NMR	(75	MHz,	DMSO‐
d6,	 δ,	 ppm):	 114.6,	 119.2,	 120.4,	 123.4,	 124.6,	 128.6,	 130.2,	
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130.7,	 133.9,	 134.7,	 136.2,	 138.9,	 140.3,	 140.9,	 143.3,	 148.0,		
148.9,	 151.6,	 161.3	 (C=O),	 166.5	 (C=O).	 MS	 (m/z	 (%)):	 407	
(M++1,	 14),	 406	 (M+,	 35),	 190	 (100),	 116	 (47),	 77	 (88).	 Anal.	
calcd.	 for	 C24H14N4O3	 (406.11):	 C,	 70.93;	 H,	 3.47;	 N,	 13.79.	
Found:	C,	70.99;	H,	3.36;	N,	13.64%.			
9‐Acetyl‐11‐phenyl‐6H‐chromeno[4,3‐d][1,2,4]triazolo[4,3‐a]	
pyrimidine‐6,7(11H)‐dione	 (5b):	 Yield:	 78%,	 crystallized	 from	
dioxane	as	pale	yellow	crystals.	M.p.:	264	 oC.	 IR	(KBr,	ν,	 cm‐1):	
1734	 (δ‐lactone),	 1682	 (COCH3),	 1656	 (CO	 amide).	 1H	 NMR	
(300	MHz,	DMSO‐d6,	δ,	ppm):	2.44	(s,	3H,	COCH3),	7.20‐8.39	(m,	
9H,	 Ar‐H).	 13C	 NMR	 (75	 MHz,	 DMSO‐d6,	 δ,	 ppm):	 22.6,	 119.2,	
120.4,	 124.6,	 128.6,	 130.2,	 130.7,	 133.9,	 136.2,	 138.9,	 140.3,	
140.9,	 143.3,	 148.9,	 151.6,	 161.3	 (C=O),	 165.3	 (C=O),	 189.6	
(C=O).	MS	(m/z	(%)):	 	373	(M++1,	15),	372	(M+,	58),	343	(62),	
289	 (34),	 213	 (49),146	 (14),	 91	 (100),	77	 (8).	Anal.	 calcd.	 for	
C20H12N4O4	 (372.09):	 C,	 64.52;	 H,	 3.25;	 N,	 15.05.	 Found:	 C,	
64.43;	H,	3.20;	N,	14.89%.	
9‐Acetyl‐11‐p‐tolyl‐6H‐chromeno[4,3‐d][1,2,4]triazolo[4,3‐a]	
pyrimidine‐6,7(11H)‐dione	 (5c):	 Yield:	 78%,	 crystallized	 from	
ethanol	 as	pale	yellow	crystals.	M.p.:	 234	 oC.	 IR	 (KBr,	ν,	 cm‐1):	
1747	 (δ‐lactone),	 1689	 (COCH3),	 1649	 (CO	 amide).	 1H	 NMR	
(300	MHz,	DMSO‐d6,	δ,	 ppm):	2.28	 (s,	3H,	ArCH3),	2.43	 (s,	3H,	
COCH3),	 7.20‐8.39	 (m,	 8H,	 Ar‐H).	MS	 (m/z	 (%)):	 	 386	 (M+,	 2)	
261	 (89),	 208	 (21),	 106	 (100),	 77	 (44).	 Anal.	 calcd.	 for	
C21H14N4O4	 (386.10):	 C,	 65.28;	 H,	 3.65;	 N,	 14.50.	 Found:	 C,	
65.17;	H,	3.49;	N,	14.38%.			
9‐Acetyl‐11‐(4‐chlorophenyl)‐6H‐chromeno[4,3‐d][1,2,4]	
triazolo[4,3‐a]pyrimidine‐6,7(11H)‐dione	 	 (5d):	 Yield:	 76%,	
crystallized	 from	dioxane	as	pale	yellow	crystals.	M.p.:	227	 oC.	
IR	 (KBr,	 ν,	 cm‐1):	 1745	 (δ‐lactone),	 1679	 (COCH3),	 1654	 (CO	
amide).	 1H	 NMR	 (300	 MHz,	 DMSO‐d6,	 δ,	 ppm):	 2.49	 (s,	 3H,	
COCH3),	 7.16‐8.25	 (m,	 8H,	 Ar‐H).	 MS	 (m/z	 (%)):	 	 407	 (M++1,	
17),	406	(M+,	14),	364	(100),	281	(43),	213	(69),	90	(95).	Anal.	
calcd.	 for	 C20H11ClN4O4	 (406.05):	 C,	 59.05;	 H,	 2.73;	 N,	 13.77.	
Found:	C,	59.00;	H,	2.78;	N,	13.65%.		
9‐Acetyl‐11‐(4‐bromophenyl)‐6H‐chromeno[4,3‐d][1,2,4]	
triazolo[4,3‐a]pyrimidine‐6,7(11H)‐dione	 	 (5e):	 Yield:	 73%,	
crystallized	 from	dioxane	as	pale	yellow	crystals.	M.p.:	268	 oC.	
IR	 (KBr,	 ν,	 cm‐1):	 1740	 (δ‐lactone),	 1680	 (COCH3),	 1664	 (CO	
amide).	 1H	 NMR	 (300	 MHz,	 DMSO‐d6,	 δ,	 ppm):	 2.46	 (s,	 3H,	
COCH3),	7.19‐8.29	(m,	8H,	Ar‐H).	MS	(m/z	(%)):	 	450	(M+,	11),	
384	 (100),	 302	 (13),	 152	 (52),	 77	 (43).	 Anal.	 calcd.	 for	
C20H11BrN4O4	 (450.00):	 C,	 53.24;	 H,	 2.46;	 N,	 12.42.	 Found:	 C,	
53.21;	H,	2.40;	N,	12.31%.		
9‐Acetyl‐11‐(4‐nitrophenyl)‐6H‐chromeno[4,3‐d][1,2,4]	
triazolo[4,3‐a]pyrimidine‐6,7(11H)‐dione	 (5f):	 Yield:	 72%,	
crystallized	from	ethanol	as	brown	solid.	M.p.:	254	oC.	IR	(KBr,	
ν,	cm‐1):	1753	(δ‐lactone),	1690	(COCH3),	1667	(CO	amide).	1H	
NMR	 (300	MHz,	DMSO‐d6,	δ,	 ppm):	2.46	 (s,	 3H,	 COCH3),	 7.25‐
8.36	(m,	8H,	Ar‐H).	MS	(m/z	(%)):		417	(M+,	24),	374	(51),	349	
(100),	213	(47),	90	(48).	Anal.	calcd.	for	C20H11N5O6	(417.07):	C,	
57.56;	H,	2.66;	N,	16.78.	Found:	C,	57.50;	H,	2.61;	N,	16.64%.			
9‐Acetyl‐11‐(4‐methoxyphenyl)‐6H‐chromeno[4,3‐d][1,2,4]	
triazolo[4,3‐a]pyrimidine‐6,7(11H)‐dione	 (5g):	 Yield:	 77%,	
crystallized	 from	 ethanol	 as	 yellow	 crystals.	 M.p.:	 222	 oC.	 IR	
(KBr,	 ν,	 cm‐1):	 1749	 (δ‐lactone),	 1683	 (COCH3),	 1660	 (CO	
amide)	cm‐1.	1H	NMR	(300	MHz,	DMSO‐d6,	δ,	ppm):	2.41	(s,	3H,	
COCH3),	 3.32	 (s,	 3H,	OCH3),	 7.24‐8.22	 (m,	 8H,	Ar‐H).	MS	 (m/z	
(%)):		403	(M++1,	6),	402	(M+,	7),	335	(100),	320	(65),	213	(22),	
77	(8).	Anal.	calcd.	for	C21H14N4O5	(402.10):	C,	62.69;	H,	3.51;	N,	
13.92.	Found:	C,	62.69;	H,	3.51;	N,	13.92%.		
Ethyl	 6,7‐dioxo‐11‐phenyl‐7,11‐dihydro‐6H‐chromeno[4,3‐d]	
[1,2,4]triazolo[4,3‐a]pyrimidine‐9‐carboxylate	 (5h):	Yield:	73%,	
crystallized	 from	 ethanol	 as	 white	 crystals.	 M.p.:	 216	 oC.	 IR	
(KBr,	 ν,	 cm‐1):	 1753	 (δ‐lactone),	 1682	 (COOEt),	 1648	 (CO	
amide).	1H	NMR	(300	MHz,	DMSO‐d6,	δ,	ppm):	1.41	(t,	J	=	7	Hz,	
3H,	CH2CH3),	4.55	(q,	 J	=	7	Hz,	2H,	CH2CH3),	7.41‐8.38	(m,	9H,	
Ar‐H).	 13C	NMR	(75	MHz,	DMSO‐d6,	δ,	ppm):	16.3,	48.4,	118.4,	
120.8,	 123.6,	 127.3,	 130.0,	 130.7,	 133.4,	 136.6,	 137.9,	 140.3,	
141.9,	 143.3,	 146.6,	 150.6,	 161.5	 (C=O),	 164.3	 (C=O),	 166.6	
(C=O).	MS	(m/z	(%)):	 	403	(M++1,	21),	402	(M+,	81),	329	(62),	
289(42),	91	(100),	77	(65).	Anal.	calcd.	for	C21H14N4O5	(402.10):	
C,	62.69;	H,	3.51;	N,	13.92.	Found:	C,	62.52;	H,	3.63;	N,	13.72%.			
Ethyl	 6,7‐dioxo‐11‐p‐tolyl‐7,11‐dihydro‐6H‐chromeno[4,3‐d]	
[1,2,4]triazolo[4,3‐a]pyrimidine‐9‐carboxylate	 	 (5i):	Yield:	72%,	
crystallized	 from	 ethanol	 as	 white	 crystals.	 M.p.:	 225	 oC.	 IR	
(KBr,	 ν,	 cm‐1):	 1753	 (δ‐lactone),	 1680	 (COOEt),	 	 1667	 (CO	
amide).	1H	NMR	(300	MHz,	DMSO‐d6,	δ,	ppm):	1.40	(t,	J	=	7	Hz,		
3H,	CH2CH3),	2.38	(s,	3H,	ArCH3),	4.56	(q,	J	=	7	Hz,	2H,	CH2CH3),		
7.39‐8.33	 (m,	 8H,	 Ar‐H).	 MS	 (m/z	 (%)):	 	 418	 (M++2,	 5),	 417	
(M++,26),	416	(M+,	100),	343	(75),	303	(35),	105	(80),	77	(38).		
Anal.	calcd.	for	C22H16N4O5	(416.11):	C,	63.46;	H,	3.87;	N,	13.46;	
Found:	C,	63.23;	H,	3.84;	N,	13.28%.		
Ethyl	 11‐(4‐chlorophenyl)‐6,7‐dioxo‐7,11‐dihydro‐6H‐
chromeno[4,3‐d][1,2,4]triazolo[4,3‐a]pyrimidine‐9‐carboxylate		
(5j):	 Yield:	 73%,	 crystallized	 from	 ethanol	 as	 white	 crystals.	
M.p.:	216	oC.	IR	(KBr,	ν,	cm‐1):	1754	(δ‐lactone),	1682	(COOEt),		
1664	(CO	amide).	1H	NMR	(300	MHz,	DMSO‐d6,	δ,	ppm):	1.41	(t,	
J	=	7	Hz,	3H,	CH2CH3),	4.56	(q,	J	=	7	Hz,	2H,	CH2CH3),		7.43‐8.41	
(m,	8H,	Ar‐H).	MS	(m/z	(%)):	 	438	(M++2,	38),	437	(M++1,	28),	
436	 (M+,	 100),	 363	 (75),	 213	 (53),	 125	 (100),	 90	 (75).	 Anal.	
calcd.	 for	 C21H13ClN4O5	 (436.06):	 C,	 57.74;	 H,	 3.00;	 N,	 12.83.	
Found:	C,	57.70;	H,	3.04;	N,	12.65%.		
Ethyl	 6,7‐dioxo‐11‐m‐tolyl‐7,11‐dihydro‐6H‐chromeno[4,3‐d]	
[1,2,4]triazolo[4,3‐a]pyrimidine‐9‐carboxylate	 	 	 (5k):	 Yield:	
70%,	 crystallized	 from	ethanol	 as	white	 crystals.	M.p.:	 225	 oC.	
IR	 (KBr,	 ν,	 cm‐1):	 1745	 (δ‐lactone),	 1680	 (COOEt),	 1661	 (CO	
amide).	1H	NMR	(300	MHz,	DMSO‐d6,	δ,	ppm):	1.41	(t,	J	=	7	Hz,	
3H,	CH2CH3),	2.29	(s,	3H,	ArCH3),	4.50	(q,	J	=	7	Hz,	2H,	CH2CH3),		
7.31‐8.37	 (m,	 8H,	 Ar‐H).	MS	 (m/z	 (%)):	 	 417	 (M++1,	 26),	 416	
(M+,	100),	343	(95),	303	(35),	213	(16),	104	(85),	77(42).		Anal.	
calcd.	 for	 C22H16N4O5	 (416.11):	 C,	 63.46;	 H,	 3.87;	 N,	 13.46.	
Found:	C,	63.23;	H,	3.84;	N,	13.28%.				
Ethyl	 11‐(4‐nitrophenyl)‐6,7‐dioxo‐7,11‐dihydro‐6H‐
chromeno[4,3‐d][1,2,4]triazolo[4,3‐a]pyrimidine‐9‐carboxylate		
(5l):	Yield:	75%,	crystallized	from	ethanol	as	white	solid.	M.p.:	
245	oC.	IR	(KBr,	ν,	cm‐1):	1721	(δ‐lactone),	1678	(COOEt),	1642	
(CO	amide).	1H	NMR	(300	MHz,	DMSO‐d6,	δ,	ppm):	1.44	(t,	J	=	7	
Hz,	3H,	CH2CH3),	4.58	(q,	J	=	7	Hz,	2H,	CH2CH3),	 	7.45‐8.42	(m,	
8H,	 Ar‐H).	MS	 (m/z	 (%)):	 	 448	 (M++1,	 18),	 447	 (M+,	 49),	 289	
(38),	91	(100),	77(70).	Anal.	 calcd.	 for	C21H13N5O7	 (447.08):	C,	
56.38;	H,	2.93;	N,	15.65.	Found:	C,	56.24;	H,	2.75;	N,	15.45%.		
6,7‐Dioxo‐N,11‐diphenyl‐7,11‐dihydro‐6H‐chromeno[4,3‐d]	
[1,2,4]triazolo[4,3‐a]pyrimidine‐9‐carboxamide	 	 (5m):	 Yield:	
74%,	 crystallized	 from	DMF	as	white	 crystals.	M.p.:	258	 oC.	 IR	
(KBr,	ν,	 cm‐1):	4432	(NH),	1750	(δ‐lactone),	1666,	1639	(2	CO	
amide).	 1H	 NMR	 (300	 MHz,	 DMSO‐d6,	 δ,	 ppm):	 6.78‐8.34	 (m,	
14H,	Ar‐H),	11.12	 (s,	 1H,	NH).	 13C	NMR	 (75	MHz,	DMSO‐d6,	δ,	
ppm):	 114.8,	 118.4,	 121.6,	 121.8,	 123.6,	 123.9,	 126.6,	 130.2,	
130.3,	 133.4,	 134.7,	 137.2,	 138.8,	 140.6,	 141.2,	 143.9,	 145.6,	
151.4,	 160.5	 (C=O),	 165.2	 (C=O),	 167.2	 (C=O).	MS	 (m/z	 (%)):		
449	(M+,	19),	329	(26),	276	(19),	202	(33),	128	(37),	111	(63),	
77	(60),	55	(100).	Anal.	calcd.	for	C25H15N5O4	(449.11):	C,	66.81;	
H,	3.36;	N,	15.58.	Found:	C,	66.77;	H,	3.26;	N,	15.43%.			
6,7‐Dioxo‐N‐phenyl‐11‐p‐tolyl‐7,11‐dihydro‐6H‐chromeno	
[4,3‐d][1,2,4]triazolo[4,3‐a]pyrimidine‐9‐carboxamide	 	 	 	 (5n):	
Yield:	76%,	crystallized	 from	DMF	as	white	crystals.	M.p.:	243	
oC.	IR	(KBr,	ν,	cm‐1):	4441	(NH),	1754	(δ‐lactone),	1688,	1646	(2	
CO	amide).	 1H	NMR	(300	MHz,	DMSO‐d6,	δ,	ppm):	2.31	 (s,	3H,	
Ar‐CH3),	6.74‐8.21	(m,	13H,	Ar‐H),	11.18	(s,	1H,	NH).	MS	(m/z	
(%)):		465	(M++2,	2),	464	(M++,	8),	463	(M+,	13),	343	(100),	213	
(17),	 119	 (97),	 91	 (81),	 77	 (26).	 Anal.	 calcd.	 for	 C26H17N5O4	
(463.13):	C,	67.38;	H,	3.70;	N,	15.11.	Found:	C,	67.30;	H,	3.79;	N,	
15.00%.		
11‐(4‐Chlorophenyl)‐6,7‐dioxo‐N‐phenyl‐7,11‐dihydro‐6H‐
chromeno[4,3‐d][1,2,4]triazolo[4,3‐a]pyrimidine‐9‐carboxamide		
(5o):	Yield:	74%,	crystallized	from	DMF	as	yellow	crystals.	M.p.:	
287	 oC.	 IR	 (KBr,	 ν,	 cm‐1):	 4448	 (NH),	 1755	 (δ‐lactone),	 1673,	
1642	(2	CO	amide).	1H	NMR	(300	MHz,	DMSO‐d6,	δ,	ppm):	6.78‐
8.34	(m,	13H,	Ar‐H),	11.21	(s,	1H,	NH).		
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MS	(m/z	(%)):	 	485	(M++2,	4),	484	(M++1,	5)	(M+,	14),	363	
(82),	 213	 (41),	 152	 (40),	 119	 (100),	 77	 (20).	 Anal.	 calcd.	 for	
C25H14ClN5O4	 (483.07):	 C,	 62.06;	 H,	 2.92;	 N,	 14.47.	 Found:	 	 C,	
62.01;	H,	2.87;	N,	14.24%.		
9‐Benzoyl‐11‐phenyl‐6H‐chromeno[4,3‐d][1,2,4]triazolo[4,3‐
a]pyrimidine‐6,7(11H)‐dione	 	 (5p):	 Yield:	 83%,	 crystallized	
from	 DMF	 as	 yellow	 crystals.	 M.p.:	 276	 oC.	 IR	 (KBr,	 ν,	 cm‐1):	
1750	(δ‐lactone),	1680	(ArCO),	1643	(CO	amide).	1H	NMR	(300	
MHz,	DMSO‐d6,	δ,	ppm):	6.89‐8.12	(m,	14H,	Ar‐H).	13C	NMR	(75	
MHz,	 DMSO‐d6,	 δ,	 ppm):	 115.2,	 118.0,	 120.8,	 121.4,	 123.0,	
124.3,	 126.1,	 130.0,	 130.6,	 131.3,	 134.4,	 134.7,	 137.0,	 141.2,	
141.7,	 142.9,	 144.3,	 153.4,	 161.7	 (C=O),	 165.8	 (C=O),	 179.7	
(C=O).	MS	(m/z	(%)):	435	(M++1,	6),	434	(M+,	20),	405	(8),	105	
(100),	77	(60).	Anal.	calcd.	for	C25H14N4O4	(434.10):	C,	69.12;	H,	
3.25;	N,	12.90.	Found:	C,	69.11;	H,	3.13;	N,	12.76%.			
9‐Benzoyl‐11‐(4‐chlorophenyl)‐6H‐chromeno[4,3‐d][1,2,4]	
triazolo[4,3‐a]pyrimidine‐6,7(11H)‐dione	 (5q):	 Yield:	 80%,	
crystallized	from	DMF	as	yellow	crystals.	M.p.:	259	oC.	IR	(KBr,	
ν,	 cm‐1):	 1750	 (δ‐lactone),	 1682	 (ArCO),	 1643	 (CO	 amide).	 1H	
NMR	 (300	MHz,	 DMSO‐d6,	 δ,	 ppm):	6.80‐8.24	 (m,	 13H,	 Ar‐H).	
MS	(m/z	(%)):	469	(M++1,	6),	468	(M+,	20),	363	(34),	105	(100),	
77	(53).	Anal.	calcd.	for	C25H13ClN4O4	(468.06):	C,	64.04;	H,	2.79;	
N,	11.95;	Found:	C,	64.01;	H,	2.45;	N,	11.67%.			
11‐Phenyl‐9‐(2‐thienylcarbonyl)‐6H‐chromeno[4,3‐d][1,2,4]	
triazolo[4,3‐a]pyrimidine‐6,7(11H)‐dione	 (5r):	 Yield:	 78%,	
crystallized	 from	 ethanol	 as	 yellow	 crystals.	 M.p.:	 244	 oC.	 IR	
(KBr,	ν,	cm‐1):	1747	(δ‐lactone),	1688	(ArCO),	1645	(CO	amide).	
1H	NMR	(300	MHz,	DMSO‐d6,	δ,	ppm):	7.36‐8.45	(m,	12H,	Ar‐H).	
MS	(m/z	(%)):	442	(M++2,	3),	441	(M++1,	7),	440	(M+,	24),	304	
(4),	111	(100),	77	(13).	Anal.	calcd.	for	C23H12N4O4S(440.06):	C,	
62.72;	H,	2.75;	N,	12.72.	Found:	C,	62.59;	H,	2.70;	N,	12.57%.	
	
2.3.1.	General	procedure	for	the	synthesis	of	compound	10b,	
h	and	m	
	
To	a	solution	of	compound	1	 (2.46	g,	0.01	mol)	 in	ethanol	
was	added	an	aqueous	solution	of	potassium	hydroxide	(1	mL,	
75%)	and	the	mixture	was	warmed	for	10	min.	in	a	water	bath	
at	80	oC	and	cooled.	To	the	resulting	clear	solution	was	added	
the	 appropriate	 chloromethylene	 compounds	 9b,	 h	 and	 m	
(0.01	mol)	dropwise	while	 stirring	 the	reaction	mixture.	After	
complete	addition,	the	reaction	mixture	was	stirred	for	further	
18	 h	 at	 room	 temperature.	 The	 solid	 that	 precipitated	 was	
filtered	 off,	 washed	 with	 water,	 dried	 and	 finally	 crystallized	
from	 DMF	 to	 give	 pure	 10b,	 h	 and	m	 (Scheme	 3)	 with	 the	
following	physical	and	spectral	data.	
2‐(2,4‐Dioxopentan‐3‐ylthio)‐3H‐chromeno[4,3‐d] 	
pyrimidine‐4,5‐dione	 (10b):	 Yield:	 82%,	 crystallized	 from	
ethanol	as	white	solid.	M.p.:	186	oC.	IR	(KBr,	ν,	cm‐1):	3444	(NH),	
1735	 (δ‐lactone),	 1714	 (COCH3),	 1640	 (CO	 amide).	 1H	 NMR	
(300	MHz,	DMSO‐d6,	δ,	ppm):	2.16	(s,	6H,	COCH3),	5.18	(s,	1H,	
CH),	7.32‐8.52	(m,	4H,	Ar‐H),	12.83	(s,	1H,	NH).	MS	(m/z	(%)):	
344	 (M+,	 15),	 274	 (100),	 188	 (51),	 119	 (34),	 91	 (23).	 Anal.	
calcd.	 for	 C16H12N2O5S	 (344.05):	 C,	 55.81;	 H,	 3.51;	 N,	 8.14.	
Found:	C,	55.67;	H,	3.43;	N,	8.07%.		
Ethyl	 2‐(4,5‐dioxo‐4,5‐dihydro‐3H‐chromeno[4,3‐d]	
pyrimidin‐2‐ylthio)‐3‐oxobutanoate	 (10h):	 Yield:	 77%,	
crystallized	from	ethanol	as	white	solid.	M.p.:	162	oC.	IR	(KBr,	ν,	
cm‐1):	 3442	 (NH),	 1741	 (δ‐lactone),	 1710	 (COCH3),	 1692	
(COOEt),	 1648	 (CO	 amide).	 1H	 NMR	 (300	 MHz,	 DMSO‐d6,	 δ,	
ppm):	1.41	(t,	 J	=	7	Hz,	3H,	CH2CH3),	2.13	(s,	3H,	COCH3),	4.50	
(q,	J	=	7	Hz,	2H,	CH2CH3),	5.12	(s,	1H,	CH),	7.20‐8.44	(m,	4H,	Ar‐
H),	 12.78	 (s,	 1H,	NH).	MS	 (m/z	 (%)):	 375	 (M++1,	 7),	 374	 (M+,	
34),	 326	 (20),	 302	 (42),	 259	 (59),	 231	 (100),	 145	 (28),	 114	
(67),	77	(18).	Anal.	calcd.	for	C17H14N2O6S	(374.06):	C,	54.54;	H,	
3.77;	N,	7.48.	Found:	C,	54.67;	H,	3.58;	N,	7.34%.	
2‐(4,5‐Dioxo‐4,5‐dihydro‐3H‐chromeno[4,3‐d]pyrimidin‐2‐
ylthio)‐3‐oxo‐N‐phenyl	 butanamide	 (10m):	 Yield:	 71%,	
crystallized	from	ethanol	as	white	solid.	M.p.:	188	oC.	IR	(KBr,	ν,	
cm‐1):	 1743	 (δ‐lactone),	 1710	 (COCH3),	 1682,	 1644	 (2	 CO	
amide).	 1H	 NMR	 (300	 MHz,	 DMSO‐d6,	 δ,	 ppm):	 1.90	 (s,	 3H,	
COCH3),	5.10	(s,	1H,	CH),	7.02‐8.26	(m,	9H,	Ar‐H),	11.38	(s,	1H,	
NH),	 13.12	 (s,	 1H,	 NH).	 MS	 (m/z	 (%)):	 423	 (M++2,	 2),	 422	
(M++1,	8),	421	(M+,	13),	343	(100),	213	(17),	119	(97),	91	(81),	
77	(26).	Anal.	calcd.	for	C21H15N3O5S	(421.07):	C,	59.85;	H,	3.59;	
N,	9.97.	Found:	C,	59.70;	H,	3.66;	N,	9.68%.			
	
2.3.2.	Coupling	of	compound	10b,	h	and	m	
	
To	a	solution	of	the	appropriate	10b,	h	and	m	(10	mmol)	in	
ethanol	(40	mL)	was	added	sodium	acetate	trihydrate	(1.36	g,	
10	mmol)	and	the	mixture	was	cooled	to		0‐5	oC	in	an	ice	bath.	
To	 the	 resulting	 cold	 solution	 was	 added	 portionwise	 a	 cold	
solution	 of	 benzenediazonium	 chloride,	 prepared	 by	
diazotizing	aniline	(10	mmol)	dissolved	in	hydrochloric	acid	(6	
M,	6	mL)	with	a	solution	of	sodium	nitrite	(0.7	g,	10	mmol)	 in	
water	 (10	mL).	After	 complete	addition	of	 the	diazonium	salt,	
the	 reaction	mixture	was	 stirred	 for	 further	 30	min	 in	 an	 ice	
bath.	The	solid	precipitated	was	filtered	off,	washed	with	water,	
dried	 and	 crystallized	 from	 DMF	 to	 give	 the	 corresponding	
products,	5b,	5h	and	5m	 	which	were	 identical	 in	all	 respects	
(M.p.,	 mixed	 m.p.	 and	 IR	 spectra)	 with	 those	 obtained	 from	
reaction	of		compound	1	with	2b,	2h	and	2m,	respectively.	
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3.	Results	and	discussion	
	
The	 thione	 derivative	1	which	was	prepared	 according	 to	
procedure	 reported	 in	 literature	 [12]	 through	 interaction	
between	 3‐ethoxycarbonylcoumarin	 and	 thiourea	 in	 ethanol	
and	 K2CO3	was	 found	 to	 be	 a	 good	 point	 to	 start.	 The	 thione	
group	 in	 combination	 with	 the	 two	 adjacent	 NH	 functions,	
provide	 a	 rich	 opportunity	 for	 heterocyclic	 construction.	 The	
homologation	of	the	thione	compound	1	by	the	interaction	with	
various	 hydrazonyl	 halides	2a‐r	 in	 dioxane	 under	 ultrasound	
irradiation	using	the	excellent	cheap	and	eco‐friendly	chitosan	
catalyst	 delivered	 the	 triazole	 derivatives	 always	 as	 a	 single	
isomer	(Scheme	1).	All	spectroscopic	and	analytical	data	were	
consistent	with	either	the	triazole	5	or	its	isomeric	structure	6	
in	good	to	excellent	yields.	The	identities	of	the	products	were	
concluded	based	on	some	spectroscopic	data,	although	infrared	
carbonyl	stretching	data	were	inconclusive,	there	was	a	distinct	
pattern	 in	 the	 chemical	 shifts	 associated	 with	 the	 carbonyl	
resonance	 in	 the	 13C	 data.	 For	 example	 the	 two	 substituted	
products	 5a	 and	 b	 showed	 carbonyl	 carbons	 resonances	
around	166‐167	ppm,	These	values	were	consistent	with	some	
appropriate	 data	 shown	 by	 similar	 compounds	 obtained	 by	
other	researchers	in	literature	[10‐12,18‐25];		hence,	based	on	
these,	one	can	conclude	that	structure	5	is	the	correct	structure	
for	the	reaction	product	rather	than	its	isomer	6.	It	is	so	clear	to	
say	 that	 in	 structure	5	 the	 carbonyl	 group	 is	 adjacent	 to	 sp3‐
hybrisized	nitrogen	atom	while	in	the	isomer	6	it	is	adjacent	to	
more	 electronegative	 sp2‐hybridized	 nitrogen	 atom	 in	 which	
the	 carbonyl	 carbon	 chemical	 shift	 should	 show	 more	
downfield	 values	 than	 those	 reported	 in	 literature.	
Unfortunately,	other	data	(remaining	1H	and	13C	NMR	data,	IR)	
were	 closely	 similar	 and	 could	 not	 realistically	 be	 used	 for	
definitive	assignments.	
A	more	 convenient	 alternative	 synthesis	 of	 the	 tetracyclic	
compound	 5	 is	 to	 use	 the	 methylthio	 derivative	 7	 of	 title	
compound	1,	 itself	prepared	 from	alkylation	of	1	with	CH3I	 in	
DMF	containing	potassium	carbonate	(its	data	consistent	with	
those	 in	 literature)	 [13].	 	 Reaction	 of	 compound	 7	 with	
hydrazonyl	halides	under	 same	conditions	used	before	 in	 this	
article	 resulted	 in	 the	 formation	 of	 compound	 5	 with	 a	
concomitant	 evolution	 of	 methyl	 mercaptan	 (Scheme	 2).	 All	
spectroscopic	and	physical	data	of	these	products	are	in	a	great	
accordance	with	 those	of	 the	products	obtained	 from	reaction	
of	compound	1	and	2.	
Another	 alternative	 two	 step	 non‐heated	 synthesis	 for	
trizole	 5	 could	 be	 accomplished	 as	 followes:	 First,	 the	
alkylation	 of	 compound	 1	 with	 	 active	 chloromethylene	
compounds	 9b,	 e	 and	 h	 in	 KOH/DMF	 at	 room	 temperature		
furnished	the	alkylthio	products	10	(Scheme	3).	The	structure	
proof	 of	 the	 latter	 products	 based	 on	 their	microanalysis	 and	
spectroscopic	 data	 (Mass,	 IR,	 1H	 NMR).	 In	 the	 1H	 NMR,	 	 two	
characteristic	 singlet	 signals	 near	 	 	 2.0	 and	 5.0	 ppm	 are	
assignable	 to	 the	 CH3CO	 and	 S–(CH)–R	protons	 in	 addition	 to	
the	characteristic	signals	of	COCH3,	COOEt	and	CONHPh	groups	
in	the	compounds	11b,	e	and	h,	respectively.	The	formation	of	
compound	11a‐c	from	reaction	of	compound	1	with	10b,	e	and	
h	 is	 analogous	 to	 S‐alkylation	 reactions	 reported	 for	 2‐
thioxopyrimidines	[26].	
Second,	coupling	of	compound	10	with	benzenediazonium	
chloride	in	ethanol	in	the	presence	of	sodium	acetate	at	0‐5	oC	
yielded	 the	corresponding	 thiohydrazonate	esters	3b,	e	and	h	
which	 undergo	 in	 situ	 Smiles	 rearrangement	 [27,28]	 followed	
by	cyclization	to	afford	products	identical	 in	all	respects	(M.p.,	
Mass	 and	 IR)	 with	 that	 obtained	 from	 reaction	 of	 each	 of	
compound	1	and	7	with	hydrazonoyl	halides	2.		
	
4.	Conclusion	
	
A	new,	efficient	and	regioselective	method	for	preparation	
of	 chromeno[4,3‐d][1,2,4]triazolo[4,3‐a]pyrimidine	 by	
reaction	 of	 	 2‐mercapto‐3H‐chromeno[4,3‐d]pyrimidine‐4,5‐
dione	 	or	 its	2‐methylthio	derivative	with	hydrazonoyl	halides		
under	 ultrasound	 irradiation	 in	 the	 presence	 of	 chitosan	 at	
ambient	 temperature	 in	 a	 short	 time	 and	 	 high	 yields	 was	
developed	and	discussed.	
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